Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Heva Health vs RxSpan MD

Heva Health
Graded #122

Lower grade

vs+17.099999999999994
RxSpan MD
Graded #4

Higher grade

The verdict

RxSpan MD takes it — 86.8/100 to 69.7/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A physician-led telehealth under board-certified founder Dr. John Diaz with a broad GLP-1 menu — compounded semaglutide and tirzepatide by injection or oral capsule, plus a brand-name lane and microdosing — on transparent all-inclusive pricing to all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxSpan MD +12
74
86
Dose & formulationRxSpan MD +37
52
89
Clinical oversightRxSpan MD +14
74
88
Labs & monitoringHeva Health +6
89
83
FulfillmentRxSpan MD +20
69
89
Contract termsRxSpan MD +30
55
85
Heva Health · left barRxSpan MD · right bar

The numbers

MetricHeva HealthRxSpan MD
WeighScore69.7/10086.8/100
GradeCB
Scorecard rank#122#4
Semaglutide$149/mo (compounded)From $194/mo
TirzepatideNot disclosed$329/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Heva Health

Graded #122 · C

Strengths

  • $149/mo entry pricing for compounded GLP-1 is competitive
  • LegitScript Certified
  • Claims licensure in all 50 states
  • Comprehensive 91-biomarker lab panel bundled — a differentiator vs compounded-GLP-1-only peers
  • Concierge care plus HRT/TRT alongside GLP-1 for an integrated longevity stack

Where it loses points

  • Tirzepatide pricing not shown — only the generic $149/mo weight-loss entry
  • Legal entity name and state of incorporation not disclosed
  • Partner pharmacy not named
  • Per-state availability not listed despite the all-50-states claim
  • Brand-name GLP-1 options (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) not addressed
RxSpan MD

Graded #4 · B

Strengths

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
  • Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Published pricing is for the compounded line — brand-name pricing isn’t itemized
  • A prescription isn’t guaranteed — a provider reviews eligibility after checkout

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard